| abstract |
The subject of the invention is the use of benzofuran derivatives with antiarrhythmic activity in particular amiodarone or dronedarone, or a pharmaceutically acceptable salt of these derivatives, for the preparation of pharmaceutical compositions intended to reduce the mortality of origin cardiac in particular cardiac arrhythmic mortality and sudden death in patients with reduced left ventricular function after myocardial infarction, without rhythm disturbances requiring antiarrhythmic therapy. |